Smart contact lens sensors integrate biochemical sensing elements, flexible electronics, power modules, and wireless readout components onto optically transparent contact lens platforms, enabling non-invasive and potentially continuous analysis of tear-derived biomarkers and ocular physiological signals. This review focuses on the translation pathway from contact lens materials and fabrication methods to sensing mechanisms, tear biomarker interpretation, and clinical deployment. We synthesize recent progress in substrate engineering, manufacturing processes, power delivery, and representative sensing strategies for intraocular pressure, glucose, electrolytes, pH, cortisol, cholesterol, and inflammatory cytokines. Instead of treating these systems as isolated examples, we compare optical/colorimetric, electrochemical, field-effect transistor, microfluidic, and wireless resonant approaches in terms of sensitivity, response time, power/readout requirements, and clinical relevance. Finally, we discuss persistent barriers, including biocompatibility, interface stability, tear-sample variability, calibration, sterilization, regulatory validation, data privacy, and compatibility with commercial contact lens manufacturing.
Gao et al. (Wed,) studied this question.